Abdominal Aortic Aneurysm and the Impact of Infectious Burden

European Journal of Vascular and Endovascular Surgery

Volumn 36, Issue 3, 2008, Pages 292-296

  Nyberg, A ^a   Skagius, E ^b   Englund, E ^a   Nilsson, I ^c   Ljungh, Å ^c   Henriksson, A E ^b  

^a Sundsvall County Hospital   (Sweden)

^b Sundsvall County Hospital   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Abdominal; Aortic aneurysm; Chlamydophila pneumoniae; Infectious burden; Rupture

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM RUPTURE; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS INFECTION;

AGED; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HERPES SIMPLEX; HUMANS; IMMUNOGLOBULIN G; MALE; PROSPECTIVE STUDIES;

EID: 49349089752     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.04.017     Document Type: Article

References (28)

1. Choke E., Cockerill G., Wilson W.R.W., Sayed S., Dawson J., Loftus I., et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30 (2005) 227-244
2. Karlsson L., Gnarpe J., Nääs J., Olsson G., Lindholm J., Steen B., et al. Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 19 (2000) 630-635
3. Karvonen M., Tuomilehto J., Pitkäniemi J., Naukkarinen A., and Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 23 (1994) 1315-1321
4. Cook P.J., Davies P., Wise R., and Honeybourne D. Chlamydia pneumoniae infection and ethnic origin. Ethn Health 3 (1998) 237-246
5. Boman J., and Hammerschlag M.R. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15 (2002) 1-20
6. Vammen S., Lindholt J.S., Østergaard L., Fasting H., and Henneberg E.W. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg 88 (2001) 1066-1072
7. Mosorin M., Juvonen J., Biancari F., Satta J., Surcel H.M., Leinonen M., et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34 (2001) 606-610
8. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D., et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71 (1994) 437-439
9. Ameriso S.F., Fridman E.A., Leiguarda R.C., and Sevlever G.E. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32 (2001) 385-391
10. Weel J.F.L., van der Hulst R.W.M., Gerrits Y., Roorda P., Feller M., Dankert J., et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 173 (1996) 1171-1175
11. Singh R.K., McMahon A.D., Patel H., Packard C.J., Rathbone B.J., and Samani N.J. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 88 (2002) 43-46
12. Mayr M., Kiechl S., Mendall M.A., Willeit J., Wick G., and Xu Q. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains; prospective results from the Bruneck study. Stroke 34 (2003) 610-615
13. Danesh J., Collins R., and Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
14. Fabricant C.G., Fabricant J., Litrenta M.M., and Minick C.R. Virus-induced atherosclerosis. J Exp Med 148 (1978) 335-340
15. Degré M. Has cytomegalovirus infection any role in the development of atherosclerosis?. Clin Microbiol Infect 8 (2002) 191-195
16. Melnick J.L., Hu C., Burek J., Adam E., and DeBakey M.E. Cytomegalovirus DNA in arterial wall of patients with atherosclerosis. J Med Virol 42 (1994) 170-174
17. Tanaka S., Komori K., Okadome K., Sugimachi K., and Mori R. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg 20 (1994) 235-243
18. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Rippin G., et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105 (2002) 15-21
19. MacSweeney S.T.R., Powell J.T., and Greenhalg R.M. Pathogenesis of abdominal aortic aneurysm. Br J Surg 81 (1994) 935-941
20. Grahame-Clarke C., Chan N.N., Andrew D., Ridgway G.L., Betteridge D.J., Emery V., et al. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108 (2003) 678-683
21. Rothenbacher D., Brenner H., Hoffmeister A., Mertens T., Persson K., and Koenig W. Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis 170 (2003) 339-345
22. Crawford E.S. Ruptured aortic aneurysm. J Vasc Surg 13 (1991) 348-350
23. Grimes D.A., and Schulz K.F. Compared to what? Finding controls for case-control studies. Lancet 365 (2005) 1429-1433
24. Sakalihasan N., Limet R., and Defawe O.D. Abdominal aortic aneurysm. Lancet 365 (2005) 1577-1589
25. Lelwala-Guruge J., Nilsson I., Ljungh A., and Wadström T. Cell surface proteins of Helicobacter pylori as antigens in an ELISA and a comparison with three commercial ELISA. Scand J Infect Dis 24 (1992) 457-465
26. Juvonen T., Biancari F., and Juvonen J. Chlamydia pneumoniae and aortic aneurysms. Scand Cardiovasc J 36 (2002) 327-328
27. Ngeh J., Anand V., and Gupta S. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin Microbiol Infect 8 (2002) 2-13
28. Ieven M.M., and Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 43 (2005) 19-24